Tag: Testing
-
Mapmygenome Completes Acquisition of dnaPower Inc. to Accelerate North American Expansion in DNA, Microbiome, Longevity and Precision Health Testing
VANCOUVER, BC, Oct. 21, 2026 /PRNewswire/ — Mapmygenome announced the completion of its acquisition of Vancouver-based dnaPower Inc., a pioneer in personal genomics. The strategic transaction expands Mapmygenome’s North American footprint and establishes a market-leading platform in DNA testing, gu…
-
BrowserStack Launches Real-Browser Load Testing Ahead of Holiday Sales
DUBLIN, Oct. 14, 2026 /PRNewswire/ — BrowserStack, the leading AI-native software testing platform, today announced the launch of BrowserStack Load Testing, which runs real browsers and API traffic in a single test so teams can see how their web apps hold up ahead of holiday and festive sales.For y…
-
SGS WINS SAF SUPPLY CHAIN EXCELLENCE AWARD AT INDIA SAF CONCLAVE & AWARDS 2026
NEW DELHI, Oct. 9, 2026 /PRNewswire/ — We are proud to announce that we have been recognized with the SAF Supply Chain Excellence Award – Testing, Inspection, Verification & Quality Assurance at the India SAF Conclave & Awards 2026, held on September 29 at Bharat Mandapam, New Delhi.This pr…
-
Gastops FluidSIGHT™ Selected for Royal Canadian Navy Evaluation Through Innovative Solutions Canada
OTTAWA, ON, Sept. 28, 2026 /PRNewswire/ — Gastops, a leader in intelligent condition monitoring and predictive maintenance solutions, has been awarded a contract under the Government of Canada’s Innovative Solutions Canada (ISC) Testing Stream program. Through the project, FluidSIGHT™ will be demon…
-
Efectis Group Strengthens Its Presence in India with the Launch of Efectis India
New subsidiary combines global fire safety expertise with local capabilities to support India’s infrastructure, industrial and energy ambitionsCHENNAI, India, Sept. 23, 2026 /PRNewswire/ — Efectis, a global leader in fire safety and explosion risk management, has officially launched Efectis India f…
-
Werfen Announces US FDA 510(k) Clearance and CE Mark for Aptiva® Antiphospholipid Syndrome IgA Reagent
FDA Clearance and CE Mark Complete Aptiva’s Antiphospholipid Syndrome Portfolio, Expanding Global Access to Comprehensive APS Testing SAN DIEGO, Sept. 23, 2026 /PRNewswire/ — Werfen today announced that its Aptiva Antiphospholipid Syndrome (APS) Immunoglobulin A (IgA) Reagent has received both U.S….
-
Mayo Clinic Laboratories Invests in Pathology Asia Holdings and LifeStrands Genomics to Advance Diagnostics and Precision Medicine
SINGAPORE, Sept. 23, 2026 /PRNewswire/ — Mayo Clinic Laboratories and Pathology Asia Holdings (PAH) have announced a strategic investment and collaboration aimed at expanding access to advanced diagnostics and precision medicine across Southeast Asia, Australia and New Zealand. …
-
New Peer-Reviewed Study Confirms Innovative Technology Shatters ESR's Four-Hour Deadline
ALCOR Scientific’s iSED® analyzers reshape lab logistics and improve patient care for one of medicine’s most widely used testsSeven times longer stability, independently validated. ESR samples on ALCOR Scientific’s iSED analyzer remained accurate for up to 28 hours at room temperature and 48 hours r…
-
Toughest Test Yet: 11 of 14 Pass AV-Comparatives EPR Test 2026
In its seventh year, AV-Comparatives’ EPR Test measures resilience against AI-built attack toolingINNSBRUCK, Austria, Sept. 15, 2026 /PRNewswire/ — In September 2025, Anthropic disrupted a state-linked group that had used its own Claude Code AI model to automate up to 90 percent of a multi-stage es…
-
EMPE Diagnostics to Unveil CircuLOK Product Range at NATCON 2026, Expanding Access to TB Drug-Resistance Diagnostics
STOCKHOLM, Sept. 10, 2026 /PRNewswire/ — EMPE Diagnostics AB today announced it will unveil the CircuLOK product range at the 81st National Conference on Tuberculosis and Chest Diseases (NATCON 2026), taking place 1–4 October in Patiala, India. The launch expands EMPE’s TB molecular resistance-test…
Latest News
About the Author
Your reliable go-to for precise and up-to-date information!
We are dedicated to accuracy, impartiality, and providing news as it unfolds, earning the trust of a wide audience. Keep up with real-time updates on the latest events and trends.